Searched for
RELABELLING OF DRUGS
Fake life-saving medicine racket busted in Delhi: Here's how they repackaged and sold drugs across several statesDelhi Police crime branch busted an interstate counterfeit medicine racket, arresting four individuals. The network allegedly sourced gover...- Rs 70,00,000 worth fake Mounjaro injections seized in Gurgaon; Police expose illegal weight-loss drug racket in NCRGurgaon Drug Racket: Authorities in Gurgaon have busted a major illegal pharmaceutical racket involving spurious Mounjaro KwikPen (tirzepat...
- GST 2.0: Key changes effective September 22; explained in FAQsThe 56th GST Council, convened on September 3, 2025, announced significant GST regime revisions effective September 22, 2025. These changes...
- Medicines, medical devices to get cheaper from Sept 22 under new GST regimeThe government has mandated pharma companies to revise the Maximum Retail Price (MRP) of medicines, formulations, and medical devices by Se...
- NPPA directs manufacturers, marketing cos to pass on benefit of reduced GST to customersManufacturers can ensure price compliance at retailer level through revised price list, the authority said in an office memorandum issued W...
- Remedy post-GST medicine shortages, government tells pharma companiesThe country has reportedly witnessed a shortage in essential medicines to treat diabetes and other life-threatening disease after July 1.
- Pre-GST medicine stocks can be relabeled with revised MRPs: CDSCOSo far, chemists had been selling old stocks of medicines at their pre-GST MRPs and pharma companies were expected to declare the new MRPs ...
- New stent prices have enough margins: Bhupendra Singh, NPPA"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...
- New stents disappear from hospitals for 're-labelling'Cardiologists told TOI on Thursday the bioresorbable vascular scaffold (BVS)— the fourth generation and most recent one that dissolves into...
- Government to act against firms creating artificial shortage of stentsThere are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...
- After India, European Union to probe Wanbury Pharma for illegal exportEMA’s involvement in the case comes two weeks after the Drugs Controller General of India gave an export certificate to Wanbury to supply d...
- HC asks pharma companies like Novartis and Cipla, Centre to resolve the drug pricing issueA bench of Justice B D Ahmed and Justice Vibhu Bakhru said representatives of the pharma companies hold a meeting with the Director of the ...
- Drug companies likely to face penalty for overcharging"Drug firms followed that practice at risk, as the matter was sub judice," admitted a senior company executive on condition of anonymity.
- Supreme Court ruling on GSK sends drug sector into huddleNational Pharma Pricing Authority is studying the judgement and will begin the exercise of calculating the amount overcharged by drug compa...
- Delhi HC extends relief period for pharma cos in drug pricing caseOther companies that have approached the court include Micro Labs, Lupin, Wockhardt, Intas Pharma, Alembic Pharma and Emcure Pharma.
- Pharma companies may get more time to re-label drugsThe government may allow pharma companies one more month from the cut-off date of July 29 to re-label their essential drug products.
- Pharma department to meet drugmakers today to sort out pricing problemsThe finance ministry last week exempted drug makers from the excise duty on repacking or relabeling, an exception available for 45 days.
- No excise duty on relabelling of drugs to comply with pricing orderThis exemption would be available for 45 days after the prices of the essential drugs are notified by National Pharma Pricing Authority.
- Pharma industry grows by 7 per cent to Rs 6,370 crore in MayThe domestic pharmaceutical market reported growth of 6.8 % at Rs 6,370 cr for the month of May 2013, IMS Health said in its report here
- New price regulation in essential medicines; Drug firms skepticalThe government may give drug firms just 45 days to comply with the upcoming pricing regime that promises cheaper essential medicines.
Load More
